WHO. World Health Organization. HIV and AIDS- Key facts. 2023.

GAC, Ghana AIDS. Commission: People Living with HIV in Ghana. 2023.

WB. The World Bank. Prevalence of HIV, total (% of population ages 15–49.)– Ghana 2021.

Hammer SM, Saag MS, Schechter M, Montaner JS, Schooley RT, Jacobsen DM, et al. Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society–USA panel. JAMA. 2006;296(7):827–43.

Article  CAS  PubMed  Google Scholar 

Gandhi RT, Bedimo R, Hoy JF, Landovitz RJ, Smith DM, Eaton EF, et al. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2022 recommendations of the International Antiviral Society–USA panel. JAMA. 2023;329(1):63–84.

Article  CAS  PubMed  Google Scholar 

Garone D, Conradie K, Patten G, Cornell M, Goemaere E, Kunene J, et al. High rate of virological re-suppression among patients failing second-line antiretroviral therapy following enhanced adherence support: a model of care in Khayelitsha, South Africa. South Afr J HIV Med. 2013;14(4):170–5.

Article  Google Scholar 

Nichols BE, Sigaloff KC, Kityo C, Hamers RL, Baltussen R, Bertagnolio S, et al. Increasing the use of second-line therapy is a cost‐effective approach to prevent the spread of drug‐resistant HIV: a mathematical modelling study. J Int AIDS Soc. 2014;17(1):19164.

Article  PubMed  PubMed Central  Google Scholar 

Hosseinipour MC, Gupta RK, Van Zyl G, Eron JJ, Nachega JB. Emergence of HIV drug resistance during first-and second-line antiretroviral therapy in resource-limited settings. J Infect Dis. 2013;207(suppl2):S49–56.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Swenson LC, Min JE, Woods CK, Cai E, Li JZ, Montaner JS, et al. HIV drug resistance detected during low-level viremia is associated with subsequent virologic failure. AIDS. 2014;28(8):1125.

Article  PubMed  Google Scholar 

NACP-Ghana. National AIDS Control Programme: 2019 Annual Report-June 2020. 2019:38.

NACP-Tanzania. National AIDS Control Program United Republic of Tanzania: National Guidelines for the Management of HIV and AIDS. 2019.

Jenkins SY, Resar D, Panos Z, Staple A, Watkins M, Ripin D, et al. Securing accelerated access to long-acting injectable cabotegravir for HIV prevention in low‐and middle‐income countries. J Int AIDS Soc. 2023;26:e26101.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Meyer-Rath G, Jamieson L, Pillay Y. What will it take for an injectable ARV to change the face of the HIV epidemic in high‐prevalence countries? Considerations regarding drug costs and operations. J Int AIDS Soc. 2023;26:e26106.

Article  PubMed  PubMed Central  Google Scholar 

Fujisaki S, Fujisaki S, Ibe S, Asagi T, Itoh T, Yoshida S, et al. Performance and quality assurance of genotypic drug-resistance testing for human immunodeficiency virus type 1 in Japan. Jpn J Infect Dis. 2007;60(2/3):113.

Article  CAS  PubMed  Google Scholar 

Sia D, Onadja Y, Hajizadeh M, Heymann SJ, Brewer TF, Nandi A. What explains gender inequalities in HIV/AIDS prevalence in sub-saharan Africa? Evidence from the demographic and health surveys. BMC Public Health. 2016;16(1):1–18.

Article  Google Scholar 

Badri M, Lawn SD, Wood R. Utility of CD4 cell counts for early prediction of virological failure during antiretroviral therapy in a resource-limited setting. BMC Infect Dis. 2008;8(1):1–8.

Article  Google Scholar 

Bennett DE. The requirement for surveillance of HIV drug resistance within antiretroviral rollout in the developing world. Curr Opin Infect Dis. 2006;19(6):607–14.

Article  PubMed  Google Scholar 

Organization WH. Guidelines: updated recommendations on HIV prevention, infant diagnosis, antiretroviral initiation and monitoring. 2021. https://iris.who.int/bitstream/handle/10665/340190/9789240022232-eng.pdf; [Accessed March 14, 2024].

Broyles LN, Luo R, Boeras D, Vojnov L. The risk of sexual transmission of HIV in individuals with low-level HIV viraemia: a systematic review. Lancet. 2023.

Montarroyos UR, Miranda-Filho DB, César CC, Souza WV, Lacerda HR, Militão Albuquerque MFP, et al. Factors related to changes in CD4 + T-cell counts over time in patients living with HIV/AIDS: a multilevel analysis. PLoS ONE. 2014;9(2):e84276.

Article  PubMed  PubMed Central  Google Scholar 

Gathe JC Jr, Ive P, Wood R, Schürmann D, Bellos NC, DeJesus E, et al. SOLO: 48-week efficacy and safety comparison of once-daily fosamprenavir/ritonavir versus twice-daily nelfinavir in naive HIV-1-infected patients. AIDS. 2004;18(11):1529–37.

Article  CAS  PubMed  Google Scholar 

Aggleton P, Yankah E, Crewe M. Education and HIV/AIDS—30 years on. AIDS Educ Prev. 2011;23(6):495–507.

Article  PubMed  Google Scholar 

Govathson C, Ndlovu N, Rambally-Greener L, Schmucker L, Chetty-Makkan CM, Miot J et al. Increasing HIV treatment literacy among people living with HIV using a novel health communication aid: evidence from KwaZulu Natal province, South Africa. medRxiv. 2023:2023.06. 15.23291430.

Mo H, King MS, King K, Molla A, Brun S, Kempf DJ. Selection of resistance in protease inhibitor-experienced, human immunodeficiency virus type 1-infected subjects failing lopinavir-and ritonavir-based therapy: mutation patterns and baseline correlates. J Virol. 2005;79(6):3329–38.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Colonno R, Rose R, McLaren C, Thiry A, Parkin N, Friborg J. Identification of I50L as the signature atazanavir (ATV)-resistance mutation in treatment-naive HIV-1-infected patients receiving ATV-containing regimens. J Infect Dis. 2004;189(10):1802–10.

Article  CAS  PubMed  Google Scholar 

Chimukangara B, Lessells RJ, Sartorius B, Gounder L, Manyana S, Pillay M, et al. HIV-1 drug resistance in adults and adolescents on protease inhibitor-based antiretroviral therapy in KwaZulu-Natal Province, South Africa. J Global Antimicrob Resist. 2022;29:468–75.

Article  CAS  Google Scholar 

Bircher RE, Ntamatungiro AJ, Glass TR, Mnzava D, Nyuri A, Mapesi H, et al. High failure rates of protease inhibitor-based antiretroviral treatment in rural Tanzania–A prospective cohort study. PLoS ONE. 2020;15(1):e0227600.

Article  CAS  PubMed  PubMed Central  Google Scholar